Vertex says Orkambi is on the blockbuster track; Advent and CVC reportedly made offers to buy inVentiv Health; the FDA approves Sanofi's Adlyxin
Type 2 diabetes is on the rise, around the world. The IMS Institute for Healthcare Informatics breaks down diabetes prevalence in Brazil, Mexico, Saudi Arabia, the U.K., and the U.S.
She will be responsible for the medical device practice's strategy and operations across all W2O Group agencies.
IBM to help analyze data about the spread of Zika; Grassley to investigate Part D program; Lilly CEO to retire
Sales of Gilead's HCV drugs fall; the DNC policy platform criticized price gouging; Janssen partners with Bristol-Myers Squibb on Opdivo combo drug
Red, a Huntsworth agency, also counted Sanofi as a new client.
The nonprofit is dedicated to curing blood cancer.
Now that it has consolidated its global agency roster, GSK Consumer Healthcare aims to increase digital marketing efforts.
Darzalex may interfere with blood testing; Kaine scrutinized for ties to pharma; medical societies are in support of bill exempting CME reporting
While analysts predict a first-in-class appearance before the FDA by 2018, many obstacles have arisen.
Despite the arrivals of new drugs, Genentech continues to be the market leader. Its drugs, Rituxan, Avastin, and Herceptin, are the category leaders, generating a total of $9.29 billion in sales.
Herceptin biosimilar meets endpoint in clinical trial; Roche plans to launch five new drugs over the next year; government seeks to block insurer deals
The drugmaker had launched the campaign for the multiple sclerosis drug in 2015.
The FDA approves generic versions of AstraZeneca's Crestor; Biogen CEO steps down; drugmakers race to develop smart inhalers
Avanir's success with Nuedexta sparked the attention of several suitors. In 2014 the company reached a deal to be sold to Otsuka Pharmaceutical for around $3.5 billion
Spending on CME rose in 2015; the FDA approves Valeant's Relistor; the Justice Department aims to block insurer merger
One oft-cited challenge to Entresto's adoption has been prior authorization requirements.
Twenty shops, including Co:Collective, Wolff Olins, and 72andSunny, have signed onto the Pledge Parental Leave coalition since March.
The FDA declines to approve Novartis biosimilar; GSK partners with Apple's ResearchKit; drugmakers partner with Lyft for clinical trial participants
Mehr was recently promoted to lead customer-centric marketing solutions at ZS Associates.
Roche's blood cancer drug fails to meet trial goal; the FDA says Valeant's psoriasis drug carries risk of suicide; Facebook tests disappearing messages
The health technology company's EVP of business growth and analytics talks about his career path, from studying medicine to leading ContextMedia:Health's commercial solutions team.
PhRMA brings on new members, Amgen partners with Daiichi Sankyo on biosimilar commercialization in Japan; Thomson Reuters to sell science unit
Scheiner has held jobs in and out of healthcare over the course of his career.
The FDA expands use for Pfizer's Prevnar 13 vaccine; an FDA panel votes in support of Novartis biosimilar; U.S. healthcare spending rises 5.5% in 2015
Globally, digital ad spend this year is expected to grow by 12.6% to $176.7 billion, accounting for 32% of all ad spend.
Gilead reportedly avoiding paying billions in taxes; Merck plans to cut R Sage's treatment for postpartum depression meets trial goal
The partnership is aimed at helping later-stage health startups grow their businesses with marketing and brand strategy advice.
U.S. cancer centers triple spending on advertising; study finds patient choice can reduce side effects; the FDA approves Shire's dry-eye drug
He is replacing Martin Golden, who was appointed head of global marketing strategy.
Purdue Pharma reportedly knew about OxyContin trafficking; Amgen's Repatha approved for monthly dosing option; Clinton proposes new healthcare measures
Work created by the FCB Health network and Ogilvy CommonHealth Worldwide named among the finalists for the 2016 MM&M Awards.
Prounis sold her stake in Flashpoint to Omnicom, which is merging the agency with four other shops to create DDB Health.
The FDA said Amgen's biosimilar of Humira is safe and effective; Juno trial halted due to patient deaths; the CMS bans Theranos founder
Executives attending Cannes Lions Health weigh in on the imbalance seen in the U.S. between branded and unbranded drug ads.
EpiPen price hikes led to syringe use; states with medical marijuana laws have drops in drug spending; Pfizer and Merck KGaA start ovarian cancer trial
Visions, challenges, and advice: Here are 100 quotes from 100 agency leaders, compiled from the MM&M Agency Issue.
Pfizer to disclose addiction risk in promo materials for opioids; Medivation considers an acquisition; Almirall expresses interest in buying Valeant drugs
U.S. companies accounted for nearly a quarter of the startups funded to celebrate Publicis' 90th anniversary.
States and insurers are lifting restrictions on HCV drugs; Teva's request to join PhRMA raises eyebrows; Merck partners with GPO
Five executives from the industry's largest holding companies discuss their move away from the traditional network structure.
A number of mergers and acquisitions among healthcare agencies in 2015 and 2016 changed the landscape.
Healthcare agencies focus on freeing pharma brands from their collaboration cocoons to work with health tech companies, while squaring away access concerns.
Ogilvy CommonHealth Worldwide, FCB Health, and McCann Health North America are North America's biggest healthcare agencies, based on 2015 revenue.
Drugmakers doled out $452 million to UK healthcare providers; GSK, Pfizer see big market in vaccines for expectant mothers; Shire ADHD drug meets endpoint
BI axes 725 U.S. jobs; Bill Gates supports current U.S. drug pricing; drugmakers are targeting smaller hospitals
Global tech PR agency Hotwire has launched a global health tech practice, overseen from London by group chief development officer Andy West.
Help us compile the most accurate and meaningful picture of salaries, job satisfaction, and trends in the healthcare market. And be entered to win one of three $200 AmEx gift cards.
GIlead Sciences' new HCV treatment receives approval; FDA adcomm votes in favor of Jardiance health-outcomes' claims; FDA names head of new oncology center
The co-founder of Mapquest.com talks about his move from online mapping to healthcare, and what he likes most meeting with clients.
The new healthcare network combines several US and European professional agencies, Omnicom said.
Opdivo nets sixth Breakthrough Therapy designation; AstraZeneca seeks rare indication to block Crestor generics; Endo mulls sale to reduce debt
The chief planning officer of North America talks about strategy and how to tell an engaging health story.
Tactics like a talking bear were employed to engage the LGBTQ community and millennials, along with a tagline promoting self-expression.
Former FDA commissioners said agency should be independent from HHS; Sanofi and BI confirm asset swap; FDA panel to vote on new Jardiance data
Brexit votes creates EU regulatory uncertainty; Obama plans to veto health saving accounts bill; broad Entresto adoption could prevent more than 28,000 deaths
David Paragamian, previously of Huntsworth Health, is the new managing director of Razorfish Health.
Mr. Sun serves as a follow-up to last year's social media campaign Free Killer Tan, and looks to encourage "UV-smart behaviors" among parents.
Women use apps to get prescriptions for birth control; BMS names Gordon to chief commercial role; Takeda's Actos may halt progression of liver disease;
The agency has hired Sally Barton as head of the U.S. healthcare practice/
Allergan is increasingly partnering with high-profile celebrities to raise awareness for its brands.
Cancer docs push HPV vaccine; GSK says experimental lung combo trumps Symbicort; Google rolls out new symptom search feature
A group of Havas agencies developed a song and a ritual for a Reckitt Benckiser campaign encouraging people to use mosquito repellant.
A new analysis suggests that $20 industry-sponsored meals may sway docs' prescribing habits.
Novartis plans to launch five biosimilars; Making A Murderer directors will create project based on J&J investigation; Biogen plans to close or sell manufacturing plant
After the Orlando shooting, gay men were turned away from blood drives. A campaign explaining why had to reexamine its strategy
Drugmakers test out virtual reality, partner with companies like Spotify, and go for the cinematic at Cannes Lions.
McCann Health was named Network of the Year at the Cannes Lions Health festival of creativity in Cannes.
TBWA/WorldHealth worked with Galderma to get rid of the traditional process in which an agency and its client interact in effort to improve the work.
Ogilvy & Mather London developed the campaign, called Breathless Choir and set to Sting's "Every Breath You Take."
The Lions Health 2016 health and wellness category winners.
The Lions Health 2016 pharma category winners.
The shortlist for Lions Health 2016's pharma category.
The shortlist for Lions Health 2016's health and wellness category.
Hillary Clinton receives more donations from pharma than republicans; biotech reps have highest salaries; NICE recommends Yervoy-Opdivo combo
The jurors advanced 103 entries in the pharma category of Lions Health. U.S. agencies accounted for 16 of them.
A trial studying Keytruda met its endpoint in first-line lung cancer patients.
Betsy Neville, former senior partner and leader of the reputation management practice for the Americas at FleishmanHillard, has launched her own healthcare communications agency.
The discontinuation of the Take It From a Fish campaign can serve as an example of the common ups-and-downs of pharma marketing.
A government watchdog criticizes the FDA; the FDA strengthens kidney warnings for Invokana and Farxiga; people with diabetes are living longer
Hospitals struggle with high drug costs; the FDA approves new weight loss device; the ADA asks docs not to tweet, but they did anyway
Health and wellness entries are up 42% to 2,024 in 2016, compared to 1,430 in 2015, while pharma entries increased 35% to 583 this year.
According to research conducted in the first quarter, the healthcare products company has a sterling image with millennials despite a series of legal judgments against the company.
Remedy Health, taking a cue from Humans of New York, offers snapshots of patients' stories.
Sproutel CEO Aaron Horowitz talks about how Jerry the Bear came to life and why endocrinologists are stocking the bear in their offices.
Physicians debate DTC tax write-off; Novo Nordisk's Victoza shows 13% benefit in reducing cardiovascular risks; Shire to acquire Pfizer bowel drug
On creativity: "Creativity can emerge from anywhere and anyone at any time. Medical breakthroughs aren't just discovered by scientists and researchers anymore."
Everything from the brand promise to the campaign solution to the case-study video — it all has to be based in authenticity, he says.
MM&M asks: What was the ROI for putting a McCann Health smiley face on the steps of the Palais?
A new Sanofi combination diabetes drug meets clinical trial targets; IBM partners with the American Diabetes Association; Dr. Reddy's to buy eight Teva drugs
Three executives shared some of the challenges women face in the workplace and how they want to shape the next generation of female leaders.
Her hire comes as the insurance giant is merging with Humana in a $37 billion deal.
The ability to pair data with a story or a human emotion is often easier for women.
FDA leader says drugmakers should develop more novel drugs; Merck to acquire Afferent for $1.25 billion; Colombia demands lower prices for Gleevec
Most healthcare consumers are women, which makes it easier for female healthcare marketers to connect and understand their needs.
The health video startup ran a campaign in which it exchanged holiday cookbooks for email addresses.
Industry lobbying group plans counteroffensive; the FDA rejected a record high amount generic drug applications; adcomm recommends Pfizer painkiller
He talks about the three qualities that make for a great campaign and why conservatism will not help drugmakers address reputational issues.
BI launched a new gamified patient support program aimed at improving adherence to its COPD medication.
Bing can identify people with cancer symptoms; an experimental rheumatoid arthritis meets trial goals; the FDA updates compassionate use rules
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- 8 ways for pharma to improve the way it uses Twitter
- Five things for pharma marketers to know: Thursday, July 28, 2016
- Infographic: Type 2 diabetes, a country-by-country snapshot
- Moving Forward — Without the Promotion
- Sponsored Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers